*Acinetobacter baumannii* is the most prevalent species of genus Acinetobacter that caused various nosocomial infections in clinical settings. *A. baumannii* is quite ubiquitous and has been found in water, air, and soil. Although the studies related to the animal infections caused by *A. baumannii* are limited, the reports have highlighted the involvement of *Acinetobacter* species in respiratory, urinary, bloodstream, and wound infections with an attributable mortality of 47% in pets ([@bib11]). The therapeutic management of carbapenem-resistant *A. baumannii* (CRAB) is challenging in clinical medicine ([@bib14]; [@bib5]). The emergence of multidrug-resistant CRAB isolates has been increasingly reported and is mainly associated with the acquisition of the *bla*NDM gene and overexpression of the *bla*OXA-23 gene in bovines and equines ([@bib9]; [@bib13]; [@bib17]). However, the majority of carbapenem-resistant phenotypes in *A. baumannii* isolates from the pets are mainly linked with the increased expression of the intrinsic genes ([@bib2]).

The data regarding the mechanisms underlying the antimicrobial resistance and molecular epidemiology of *Acinetobacter* species from the veterinary origin are limited compared to the *A. baumannii* strains from humans. However, the studies have revealed that the *A. baumannii* isolates from veterinary sources may harbor identical antimicrobial resistant determinants as well as share the identical clonal lineages as human strains suggesting a common source of infection ([@bib18]; [@bib12]). Here, we have described a CRAB isolate harboring the *bla*OXA-23 gene from a pet cat suffering from urinary tract infection.

A two-years-old pet cat was brought to our pet clinic with dysuria and hematuria. The urine sample was aseptically collected, which showed significant bacteriuria, and *A. baumannii* was solely obtained. The cat was having a history of persistent fever, pyuria, anorexia, weight loss, postural changes, and mood disorders from the last three months, which were previously attempted to treat with multiple courses of antimicrobial agents empirically. Initially, the oral amoxicillin-clavulanate suspension was administered at a dose rate of 62.5 mg/cat PO twice daily for 14 days, followed by ciprofloxacin at a dose rate of 6 mg/kg PO q12h for 10 days.

The *A. baumannii* isolate was identified by amplification of the *recA* gene and ITS region in a multiplex PCR as described previously, as well as the amplification of the *bla*OXA-51 gene ([@bib5]; [@bib4]). The broth microdilution method was used to determine the minimum inhibitory concentrations (MICs) according to the CLSI guidelines ([@bib1]). The genes encoding the carbapenem resistance and the presence of insertion element i.e., IS*Aba1*, were detected using PCR as described previously using specific primers ([@bib5]). The PCR was performed to detect the presence of 16S rRNA methyltransferase genes (*arm*A, *rmt*A, *rmt*B, *rmt*C, *rmt*D, and *rmt*E) and aminoglycoside modifying enzymes (AMEs) i.e., *aphA1, aphA6, aadB, aadA1*, and *aacC1* and tetracycline and sulfonamide resistant genes including *tetA, tetB, sul1, sul2*, and *sul3* genes ([@bib6]). The isolates were also screened for plasmid-mediated quinolone resistance genes (*qnrA, qnrB*, and *qnrS*) as well as mutations in the quinolone resistance-determining region by sequencing *gyrA* and *parC* gene ([@bib3]). The multi-locus sequence typing (MLST) was performed using primers recommended by the MLST database for *A. baumannii* following the Pasteur scheme.

The strain was susceptible only to colistin (MIC 0.5 μg/ml), and tigecycline (MIC 1 μg/ml). The higher MICs of imipenem (MIC 16 μg/ml), meropenem (MIC 32 μg/ml), ceftazidime, cefotaxime, ceftriaxone (MIC 64 μg/ml), cefepime (MIC 32 μg/ml), piperacillin-tazobactam (MIC 128/4 μg/ml), and ampicillin-sulbactam (MIC 64/32 μg/ml) were linked with the production of *bla*OXA-23 (Opazo et al. 2012; [@bib5]). The resistance to aminoglycoside i.e., MICs of amikacin (MIC 1024 μg/ml), gentamicin, and tobramycin (MIC 512 μg/ml) was attributed to the presence of 16S rRNA methyltransferase genes i.e., the *armA* gene as well as AMEs i.e., *aphA6, aadB*, and *aacC1*. Moreover, the MIC of trimethoprim-sulfamethoxazole was 16/304 μg/ml attributed to the presence of the *sul2* gene. The *A. baumannii* isolates showed resistance to tetracycline/doxycycline with a doxycycline MIC equal to 128 μg/ml, and it was related to the presence of the *tetB* gene. The strain was found resistant to ciprofloxacin (MIC 16 μg/ml), which was attributed to the mutation (Ser83Leu) in the *gyrA* gene. The genes conferring resistance to different antimicrobial agents that were found in the *A. baumannii* strain are summarized in Table [I](#tbl1){ref-type="table"}. The IS*Aba1* was found upstream to the *bla*OXA-51 and *bla*OXA-23 genes.

###### 

Resistance genes detected in the *A. baumannii* strain isolated in a urine sample from the urinary tract infection suffering cat.
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  Antibiotic category                Mechanism                                         Resistance associated gene        Resistance phenotypes
  ---------------------------------- ------------------------------------------------- --------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Aminoglycosides                    16S rRNA methyltransferase genes                  *armA*                            Amikacin^[a](#FNt1){ref-type="table-fn"}^, Gentamicin^[b](#FNt2){ref-type="table-fn"}^, Tobramycin^[b](#FNt2){ref-type="table-fn"}^
  Aminoglycoside modifying enzymes   *aphA6*, *aadB*, and *aacC1*                                                        
  Carbapenems                        Oxacillinases                                     *blaOXA-23*                       Imipenem^[c](#FNt3){ref-type="table-fn"}^, Meropenem^[d](#FNt4){ref-type="table-fn"}^, Ceftazidime^[e](#FNt5){ref-type="table-fn"}^, Cefotaxime^[e](#FNt5){ref-type="table-fn"}^, Ceftriaxone^[e](#FNt5){ref-type="table-fn"}^, Cefepime^[f](#FNt6){ref-type="table-fn"}^, Piperacillin-tazobactam^[g](#FNt7){ref-type="table-fn"}^, Ampicillin-sulbactam^[h](#FNt8){ref-type="table-fn"}^
  Fluoroquinolones                   Quinolones Resistance Determining Region (QRDR)   *gyrA* gene mutation (Ser83Leu)   Ciprofloxacin^[i](#FNt9){ref-type="table-fn"}^
  Sulfonamides                       Dihydropteroate synthase                          *Sul2*                            Sulfamethoxazole-Trimethoprim^[j](#FNt10){ref-type="table-fn"}^
  Tetracyclines                      Tetracycline efflux MFS transporter               *tetB*                            Doxycycline^[k](#FNt11){ref-type="table-fn"}^
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The concerns related to the possible threats of the *bla*OXA-23 harboring CRAB among the pets and other farm animals have been increasing ([@bib2]). The information on *A. baumannii* in veterinary settings is, however, limited, and data related to the comparison of strains isolated from the humans and veterinary sources are quite inadequate ([@bib16]). From Pakistan, this is the very first report of extensively drug-resistant (XDR) CRAB isolates harboring the acquired the *bla-*OXA-23 and *armA* genes from an infected pet cat, which drives the attention towards the possible transmission of these XDR pathogens from the companion animals to humans.

The *bla*OXA-23 gene is a major cause of carbapenem resistance throughout the world; therefore, it can be considered a virulence marker and is located on the chromosome as well as on the plasmids. Moreover, the studies have found a strong correlation between the occurrence of the *bla*OXA-23 gene and multidrug-resistant phenotypes ([@bib10]; [@bib19]; [@bib5]).

The MLST has shown that the *A. baumannii* strain belonged to the sequence type 2 (ST2), and the eBURST analysis has revealed that it corresponded to the international clonal lineage 2. The study conducted by Tada and his colleagues concluded that there is worldwide dissemination of this clone also harboring the *bla*OXA-23 and *armA* genes but does not suggest the human-to animal transmission ([@bib15]). Notably, the *A. baumannii* ST2 has been extensively isolated from humans, while some of the recent reports have also indicated the presence of ST2 in pets ([@bib12]). The carbapenem-resistant isolates in these studies were found to possess the intrinsic *bla*OXA-51 gene solely or accompanied by the acquired the *bla*OXA-23-like genes. Interestingly, the *A. baumannii* isolates were reported among the pets living in the community ([@bib7]). Although the data is quite limited regarding the carriage of *Acinetobacter* species beyond the veterinary clinical settings, more than a few studies during the recent few years have detected the *A. baumannii* isolates in the community among domestic birds, dogs, livestock, and other large animals. These studies specify that the incidence of *A. baumannii* infections among animals is increasing and these animals may serve as a reservoir for *A. baumannii*, particularly carbapenem-resistant strains, due to their selective advantage compared to the susceptible strains ([@bib10]; [@bib16]).

This study has reported an extensively drug-resistant *A. baumannii*, harboring the *bla*OXA-23 gene and other resistant associated genes isolated from a companion animal previously treated with multiple empirical antimicrobial courses. The infected pets may contribute to the pool of multidrug-resistant clinically relevant bacteria and their interaction with the human may transmit these pathogens to humans. The extensive epidemiological studies are essential for a better understanding of the extent of distribution, risk factors, and the directions of transmission of these multidrug-resistant strains.
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